Summary
Pfizer Inc. (PFE) filed a Form 8-K on April 19, 2006, to report its first quarter 2006 financial results. The core of this filing is the incorporation of a press release announcing these results, which provides investors with key operational and financial performance metrics for the period ending April 18, 2006. While the 8-K itself is brief and primarily serves as a notification and vehicle for attaching the press release, the attached press release (Exhibit 99.1) is the critical document for investors seeking details on Pfizer's performance. Investors should review the press release for information regarding revenue, earnings, segment performance, and any forward-looking guidance provided by the company for the upcoming quarters.
Key Highlights
- 1Pfizer Inc. announced its financial results for the first quarter of 2006 via a press release.
- 2The Form 8-K filing on April 19, 2006, incorporates this press release as Exhibit 99.1.
- 3This filing is the primary method for disseminating the company's Q1 2006 financial performance to the public.
- 4Investors can find detailed financial and operational information within the referenced press release.
- 5The event date reported is April 18, 2006, indicating the results pertain to the quarter ending on or around this date.
- 6The filing serves as a standard disclosure mechanism for material financial events.
- 7Pfizer's principal executive offices are located at 235 East 42nd Street, New York, New York.